摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

t-butyl (3R)-3-[(t-butyldiphenylsilyl)oxy]-3,6-dihydropyridine-1(2H)-carboxylate | 804500-78-5

中文名称
——
中文别名
——
英文名称
t-butyl (3R)-3-[(t-butyldiphenylsilyl)oxy]-3,6-dihydropyridine-1(2H)-carboxylate
英文别名
(R)-N-tert-butoxycarbonyl-5-(tert-butyldiphenylsilyloxy)-3-piperidene;tert-butyl (3R)-3-[tert-butyl(diphenyl)silyl]oxy-3,6-dihydro-2H-pyridine-1-carboxylate
t-butyl (3R)-3-[(t-butyldiphenylsilyl)oxy]-3,6-dihydropyridine-1(2H)-carboxylate化学式
CAS
804500-78-5
化学式
C26H35NO3Si
mdl
——
分子量
437.654
InChiKey
USKNCJRUGFEALB-OAQYLSRUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    483.3±45.0 °C(Predicted)
  • 密度:
    1.08±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.74
  • 重原子数:
    31
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    38.8
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    t-butyl (3R)-3-[(t-butyldiphenylsilyl)oxy]-3,6-dihydropyridine-1(2H)-carboxylate碳酸氢钠 Oxone1,1,1-三氟丙酮三氟化硼乙醚 、 edetate disodium 作用下, 以 乙醚乙腈 为溶剂, 反应 2.0h, 生成 (3S,4S,5R)-N-tert-butoxycarbonyl-3-(tert-butyldiphenylsilyloxy)-4-hydroxy-5-methylpiperidine
    参考文献:
    名称:
    N -Boc -5-羟基-3-哌啶烯作为常见结构单元的多种1-氮杂糖的新途径
    摘要:
    描述了一种合成具有异头位置氮原子的各种1-氮杂双胍的新的通用方法。易于获得的手性N -Boc-5-羟基-3-哌啶3通过立体选择性环氧化和区域选择性环裂解,以高度立体可控的方式转化为异黄花碱(2),高异黄花碱(13)和5'-脱氧异黄花碱(14)。 。此外,3,4,5- trihydroxypiperidines(所有四种立体异构体的合成18 - 21)被划分为1-azasugar型葡糖苷酶抑制剂是立体选择性地从(手性)啶实现3。
    DOI:
    10.1021/jo050519j
  • 作为产物:
    描述:
    (R)-N-tert-butoxycarbonyl-5-acetoxy-3-piperidene 在 咪唑4-二甲氨基吡啶 、 phosphate buffer 、 Pseudomonas cepacia lipase 、 ceramics 作用下, 以 二氯甲烷丙酮 为溶剂, 反应 21.0h, 生成 t-butyl (3R)-3-[(t-butyldiphenylsilyl)oxy]-3,6-dihydropyridine-1(2H)-carboxylate
    参考文献:
    名称:
    N -Boc -5-羟基-3-哌啶烯作为常见结构单元的多种1-氮杂糖的新途径
    摘要:
    描述了一种合成具有异头位置氮原子的各种1-氮杂双胍的新的通用方法。易于获得的手性N -Boc-5-羟基-3-哌啶3通过立体选择性环氧化和区域选择性环裂解,以高度立体可控的方式转化为异黄花碱(2),高异黄花碱(13)和5'-脱氧异黄花碱(14)。 。此外,3,4,5- trihydroxypiperidines(所有四种立体异构体的合成18 - 21)被划分为1-azasugar型葡糖苷酶抑制剂是立体选择性地从(手性)啶实现3。
    DOI:
    10.1021/jo050519j
点击查看最新优质反应信息

文献信息

  • Conversion of chiral unsaturated cyanohydrins into chiral carba- and heterocycles via ring-closing metathesis
    作者:Adrianus M.C.H. van den Nieuwendijk、Amar B.T. Ghisaidoobe、Herman S. Overkleeft、Johannes Brussee、Arne van der Gen
    DOI:10.1016/j.tet.2004.07.103
    日期:2004.11
    Aliphatic unsaturated cyanohydrins 1-3 served as starting materials in the synthesis of a set of new chiral unsaturated cyclic 1,2-ethanolamines. Combining a Grignard addition-NaBH4 reduction sequence with a ring-closing metathesis afforded unsaturated cyclic 1,2-ethanolamines 7-11 and 22-25 in good yields and high ee (96-99%). The conversion of cyanohydrins 1-3 via a DIBAL reduction-transimination-NaBH4 reduction sequence, using allylamine, followed by ring-closing metathesis yielded tetrahydropyridines 28, tetrahydroazepinols 33 and tetrahydroazocinols 34 in high yields and excellent ee (97-99%). (C) 2004 Elsevier Ltd. All rights reserved.
  • A short and concise synthesis of isofagomine, homoisofagomine, and 5′-deoxyisofagomine
    作者:Hidekazu Ouchi、Yukiko Mihara、Hitomi Watanabe、Hiroki Takahata
    DOI:10.1016/j.tetlet.2004.07.127
    日期:2004.9
    A short and concise synthesis of isofagomine derivatives via the epoxidation of chiral N-Boc-5-hydroxy-3-piperidene, followed by regioselective epoxide ring opening is described. This constitutes the first reported synthesis of homoisofagomine and the 5'-deoxyisofagomine. (C) 2004 Elsevier Ltd. All rights reserved.
  • A New Route to Diverse 1-Azasugars from <i>N</i>-Boc-5-hydroxy-3-piperidene as a Common Building Block
    作者:Hidekazu Ouchi、Yukiko Mihara、Hiroki Takahata
    DOI:10.1021/jo050519j
    日期:2005.6.1
    for the synthesis of a variety of 1-azasugars with a nitrogen atom at the anomeric position is described. The readily available chiral N-Boc-5-hydroxy-3-piperidene 3 is transformed to isofagomine (2), homoisofagomine (13), and 5‘-deoxyisofagomine (14) via stereoselective epoxidation and regioselective ring-cleavage in a highly stereocontrolled manner. In addition, the synthesis of all four stereoisomers
    描述了一种合成具有异头位置氮原子的各种1-氮杂双胍的新的通用方法。易于获得的手性N -Boc-5-羟基-3-哌啶3通过立体选择性环氧化和区域选择性环裂解,以高度立体可控的方式转化为异黄花碱(2),高异黄花碱(13)和5'-脱氧异黄花碱(14)。 。此外,3,4,5- trihydroxypiperidines(所有四种立体异构体的合成18 - 21)被划分为1-azasugar型葡糖苷酶抑制剂是立体选择性地从(手性)啶实现3。
  • Docking and SAR studies of d- and l-isofagomine isomers as human β-glucocerebrosidase inhibitors
    作者:Atsushi Kato、Saori Miyauchi、Noriko Kato、Robert J. Nash、Yuichi Yoshimura、Izumi Nakagome、Shuichi Hirono、Hiroki Takahata、Isao Adachi
    DOI:10.1016/j.bmc.2011.04.011
    日期:2011.6
    We report the structure-activity relationship of a series of D-, and L-isofagomine and fagomine isomers as glycosidase inhibitors. Our study revealed that a positive charge at the anomeric position of D-isofagomines enhanced the potency toward beta-glycosidases, while the epimerization at the C3 OH group drastically reduced their inhibitory potency by over three orders of magnitude. Furthermore, D-3,4-di-epi-isofagomine abolished their inhibition activities against all enzymes. L-Isofagomine was also a fairly potent inhibitor of human beta-glucocerebrosidase, with an IC50 value of 8.7 mu M. A molecular docking study revealed that the positions and orientations of the piperidine ring of D-3-epi-isofagomine in the binding site was similar to that of D-isofagomine, while D-3-epi-isofagomine missed the hydrogen bond interactions between Asp127 and the 3-OH group and between Trp179 and the 3-OH group. Furthermore, the top 10 docking models ranked by IFDscore suggested that D-3,4-di-epi-isofagomine can not bind to beta-glucocerebrosidase at a stable interaction mode. These results provide an insight into the structural requirements of isofagomine isomers for developing a new type of pharmacological chaperone for Gaucher disease. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(2-溴乙氧基)-特丁基二甲基硅烷 骨化醇杂质DCP 马来酸双(三甲硅烷)酯 顺式-二氯二(二甲基硒醚)铂(II) 顺-N-(1-(2-乙氧基乙基)-3-甲基-4-哌啶基)-N-苯基苯酰胺 降钙素杂质13 降冰片烯基乙基三甲氧基硅烷 降冰片烯基乙基-POSS 间-氨基苯基三甲氧基硅烷 镁,氯[[二甲基(1-甲基乙氧基)甲硅烷基]甲基]- 锑,二溴三丁基- 铷,[三(三甲基甲硅烷基)甲基]- 铂(0)-1,3-二乙烯-1,1,3,3-四甲基二硅氧烷 钾(4-{[二甲基(2-甲基-2-丙基)硅烷基]氧基}-1-丁炔-1-基)(三氟)硼酸酯(1-) 金刚烷基乙基三氯硅烷 辛醛,8-[[(1,1-二甲基乙基)二甲基甲硅烷基]氧代]- 辛甲基-1,4-二氧杂-2,3,5,6-四硅杂环己烷 辛基铵甲烷砷酸盐 辛基衍生化硅胶(C8)ZORBAX?LP100/40C8 辛基硅三醇 辛基甲基二乙氧基硅烷 辛基三甲氧基硅烷 辛基三氯硅烷 辛基(三苯基)硅烷 辛乙基三硅氧烷 路易氏剂-3 路易氏剂-2 路易士剂 试剂3-[Tris(trimethylsiloxy)silyl]propylvinylcarbamate 试剂2-(Trimethylsilyl)cyclopent-2-en-1-one 试剂11-Azidoundecyltriethoxysilane 西甲硅油杂质14 衣康酸二(三甲基硅基)酯 苯胺,4-[2-(三乙氧基甲硅烷基)乙基]- 苯磺酸,羟基-,盐,单钠聚合甲醛,1,3,5-三嗪-2,4,6-三胺和脲 苯甲醇,a-[(三苯代甲硅烷基)甲基]- 苯基二甲基氯硅烷 苯基二甲基乙氧基硅 苯基乙酰氧基三甲基硅烷 苯基三辛基硅烷 苯基三甲氧基硅烷 苯基三乙氧基硅烷 苯基三丁酮肟基硅烷 苯基三(异丙烯氧基)硅烷 苯基三(2,2,2-三氟乙氧基)硅烷 苯基(3-氯丙基)二氯硅烷 苯基(1-哌啶基)甲硫酮 苯乙基三苯基硅烷 苯丙基乙基聚甲基硅氧烷 苯-1,3,5-三基三(三甲基硅烷)